Clinical Trial
Published on 07 Feb 2024
A prospective randomized controlled trial to determine the safety and efficacy of extracorporeal shock waves therapy for primary prevention of subclinical cardiotoxicity in breast cancer patients without a cardiovascular risk treated with doxorubicin
in Cardio-Oncology
- 1,946 views
- 1 citation